p204 protein overcomes the inhibition of core binding factor α-1-mediated osteogenic differentiation by Id helix-loop-helix proteins

Molecular Biology of the Cell

Volumn 19, Issue 5, 2008, Pages 2113-2126

  Luan, Yi ^a,b   Yu, Xiu Ping ^b   Yang, Ning ^a   Frenkel, Sally ^a   Chen, Lin ^c   Liu, Chuan Ju ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INHIBITOR OF DIFFERENTIATION PROTEIN; OSTEOCALCIN; PROTEASOME; PROTEIN P204; REGULATOR PROTEIN; TRANSCRIPTION FACTOR RUNX2; UBIQUITIN;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CORE BINDING FACTOR ALPHA SUBUNITS; FEMALE; HELIX-LOOP-HELIX MOTIFS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MICE; MICE, INBRED BALB C; NUCLEAR EXPORT SIGNALS; NUCLEAR PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN;

EID: 48249122680     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-10-1057     Document Type: Article

References (81)

1. Alway, S. E., Degens, H., Lowe, D. A., and Krishnamurthy, G. (2002). Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R411-R422.
2. Ambili, M., and Sudhakaran, P. R. (1999). Modulation of neutral matrix metalloproteinases of involuting rat mammary gland by different cations and glycosaminoglycans. J. Cell Biochem. 73, 218-226.
3. Amthor, H., Christ, B., Rashid-Doubell, F., Kemp, C. F., Lang, E., and Patel, K. (2002). Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev. Biol. 243, 115-127.
4. Asefa, B., Dermott, J. M., Kaldis, P., Stefanisko, K., Garfinkel, D. J., and Keller, J. R. (2006). p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation. FEBS Lett. 580, 1205-1214.
5. Attisano, L., and Wrana, J. L. (2002). Signal transduction by the TGF-beta superfamily. Science 296, 1646-1647.
6. Benezra, R., Davis, R. L., Lassar, A., Tapscott, S., Thayer, M., Lockshon, D., and Weintraub, H. (1990a). Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann. N Y Acad. Sci. 599, 1-11.
7. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., and Weintraub, H. (1990b). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
8. Berse, M., Bounpheng, M., Huang, X., Christy, B., Pollmann, C., and Dubiel, W. (2004). Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J. Mol. Biol. 343, 361-370.
9. Bounpheng, M. A., Dimas, J. J., Dodds, S. G., and Christy, B. A. (1999). Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J. 13, 2257-2264.
10. Buitenhuis, M., van Deutekom, H. W., Verhagen, L. P., Castor, A., Jacobsen, S. E., Lammers, J. W., Koenderman, L., and Coffer, P. J. (2005). Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood 105, 4272-4281.
11. Choubey, D., Snoddy, J., Chaturvedi, V., Toniato, E., Opdenakker, G., Thakur, A., Samanta, H., Engel, D. A., and Lengyel, P. (1989). Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J. Biol. Chem. 264, 17182-17189.
12. Dauffy, J., Mouchiroud, G., and Bourette, R. P. (2006). The interferon-inducible gene, Ifi204, is transcriptionally activated in response to M-CSF, and its expression favors macrophage differentiation in myeloid progenitor cells. J. Leukoc. Biol. 79, 173-183.
13. Deed, R. W., Armitage, S., and Norton, J. D. (1996). Nuclear localization and regulation of Id protein through an E protein-mediated chaperone mechanism. J. Biol. Chem. 271, 23603-23606.
14. Deftos, M. L., Huang, E., Ojala, E. W., Forbush, K. A., and Bevan, M. J. (2000). Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13, 73-84.
15. Deschamps, S., Meyer, J., Chatterjee, G., Wang, H., Lengyel, P., and Roe, B. A. (2003). The mouse Ifi200 gene cluster: genomic sequence, analysis, and comparison with the human HIN-200 gene cluster. Genomics 82, 34-46.
16. Ding, B., Liu, C. J., Huang, Y., Hickey, R. P., Yu, J., Kong, W., and Lengyel, P. (2006a). p204 is required for the differentiation of P19 murine embryonal carcinoma cells to beating cardiac myocytes: its expression is activated by the cardiac GATA4, NKX2.5, and TBX5 proteins. J. Biol. Chem. 281, 14882-14892.
17. Ding, B., Liu, C. J., Huang, Y., Yu, J., Kong, W., and Lengyel, P. (2006b). p204 protein overcomes the inhibition of the differentiation of P19 murine embryonal carcinoma cells to beating cardiac myocytes by Id proteins. J. Biol. Chem. 281, 14893-14906.
18. Ducy, P. (2000). Cbfa 1, a molecular switch in osteoblast biology. Dev. Dyn. 219, 461-471.
19. Ducy, P., Schinke, T., and Karsenty, G. (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501-1504.
20. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. (1997). Osf2/Cbfa 1, a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
21. Eliazer, S., Spencer, J., Ye, D., Olson, E., and Ilaria, R. L., Jr. (2003). Alteration of Mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol. Cell Biol. 23, 482-492.
22. Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., and Nishida, E. (1997). CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308-311.
23. Gerace, L. (1995). Nuclear export signals and the fast track to the cytoplasm. Cell 82, 341-344.
24. Gribaudo, G., Riera, L., De Andrea, M., and Landolfo, S. (1999). The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. FEBS Lett. 456, 31-36.
25. Harhaj, E. W., and Sun, S. C. (1999). Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell Biol. 19, 7088-7095.
26. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
27. Hertel, L., Rolle, S., De Andrea, M., Azzimonti, B., Osello, R., Gribaudo, G., Gariglio, M., and Landolfo, S. (2000). The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene 19, 3598-3608.
28. Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U., and Nordheim, A. (1999). Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845.
29. Iavarone, A., Garg, P., Lasorella, A., Hsu, J., and Israel, M. A. (1994). The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8, 1270-1284.
30. Jen, Y., Manova, K., and Benezra, R. (1997). Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 208, 92-106.
31. Jen, Y., Weintraub, H., and Benezra, R. (1992). Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6, 1466-1479.
32. Karlsson, M., Mathers, J., Dickinson, R. J., Mandl, M., and Keyse, S. M. (2004). Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J. Biol. Chem. 279, 41882-41891.
33. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766.
34. Kim, H. J., Chung, H., Yoo, Y. G., Kim, H., Lee, J. Y., Lee, M. O., and Kong, G. (2007). Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol. Cancer Res. 5, 321-329.
35. Komori, T. (2003). Requisite roles of Runx2 and Cbfb in skeletal development. J. Bone Miner. Metab. 21, 193-197.
36. Komori, T. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
37. Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E. P., Yoneda, Y., Yanagida, M., Horinouchi, S., and Yoshida, M. (1998). Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540-547.
38. Kundu, M. et al. (2002). Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat. Genet. 32, 639-644.
39. Kurooka, H., and Yokota, Y. (2005). Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors. J. Biol. Chem. 280, 4313-4320.
40. Lasorella, A., Noseda, M., Beyna, M., Yokota, Y., and Iavarone, A. (2000). Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407, 592-598.
41. Lee, B., Thirunavukkarasu, K., Zhou, L., Pastore, L., Baldini, A., Hecht, J., Geoffroy, V., Ducy, P., and Karsenty, G. (1997). Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16, 307-310.
42. Lee, K. S. et al. (2000). Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell Biol. 20, 8783-8792.
43. Lembo, M., Sacchi, C., Zappador, C., Bellomo, G., Gaboli, M., Pandolfi, P. P., Gariglio, M., and Landolfo, S. (1998). Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster. Oncogene 16, 1543-1551.
44. Liu, C., Wang, H., Zhao, Z., Yu, S., Lu, Y. B., Meyer, J., Chatterjee, G., Deschamps, S., Roe, B. A., and Lengyel, P. (2000). MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol. Cell Biol. 20, 7024-7036.
45. Liu, C. J., Chang, E., Yu, J., Carlson, C. S., Prazak, L., Yu, X. P., Ding, B., Lengyel, P., and Di Cesare, P. E. (2005). The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation. J. Biol. Chem. 280, 2788-2796.
46. Liu, C. J., Ding, B., Wang, H., and Lengyel, P. (2002). The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol. Cell Biol. 22, 2893-2905.
47. Liu, C. J., Wang, H., and Lengyel, P. (1999). The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription. EMBO J. 18, 2845-2854.
48. Luan, Y., Yu, X. P., Xu, K., Ding, B., Yu, J., Huang, Y., Yang, N., Lengyel, P., Di Cesare, P. E., and Liu, C. (2007). The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity. J. Biol. Chem. 282, 16860-16870.
49. Ludlow, L. E., Johnstone, R. W., and Clarke, C. J. (2005). The HIN-200 family: more than interferon-inducible genes? Exp. Cell Res. 308, 1-17.
50. Lyden, D. et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677.
51. Maeda, Y., Tsuji, K., Nifuji, A., and Noda, M. (2004). Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. J. Cell Biochem. 93, 337-344.
52. Miyazono, K., Kusanagi, K., and Inoue, H. (2001). Divergence and convergence of TGF-beta/BMP signaling. J. Cell Physiol. 187, 265-276.
53. Miyazono, K., ten Dijke, P., and Heldin, C. H. (2000). TGF-beta signaling by Smad proteins. Adv. Immunol. 75, 115-157.
54. Moss, T., and Stefanovsky, V. Y. (2002). At the center of eukaryotic life. Cell 109, 545-548.
55. Mundlos, S., and Olsen, B. R. (1997). Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 11, 227-233.
56. Mundlos, S. et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
57. Munz, B., Hildt, E., Springer, M. L., and Blau, H. M. (2002). RIP2, a checkpoint in myogenic differentiation. Mol. Cell Biol. 22, 5879-5886.
58. Nakashima, K., Takizawa, T., Ochiai, W., Yanagisawa, M., Hisatsune, T., Nakafuku, M., Miyazono, K., Kishimoto, T., Kageyama, R., and Taga, T. (2001). BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. USA 98, 5868-5873.
59. Nifuji, A., Kellermann, O., and Noda, M. (2004). Noggin inhibits chondrogenic but not osteogenic differentiation in mesodermal stem cell line C1 and skeletal cells. Endocrinology 145, 3434-3442.
60. Nishimoto, T., Takahashi, T., and Basilico, C. (1980). A temperature-sensitive mutation affecting S-phase progression can lead to accumulation of cells with a G2 DNA content. Somatic Cell Genet. 6, 465-476.
61. Nishimura, R., Hata, K., Harris, S. E., Ikeda, F., and Yoneda, T. (2002). Core-binding factor alpha(1) (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31, 303-312.
62. Ogata, T., Wozney, J. M., Benezra, R., and Noda, M. (1993). Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl. Acad. Sci. USA 90, 9219-9222.
63. Ossareh-Nazari, B., Bachelerie, F., and Dargemont, C. (1997). Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141-144.
64. Ouyang, X. S., Wang, X., Ling, M. T., Wong, H. L., Tsao, S. W., and Wong, Y. C. (2002). Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23, 721-725.
65. Pammer, J., Reinisch, C., Kaun, C., Tschachler, E., and Wojta, J. (2004). Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells. Endothelium 11, 175-180.
66. Peng, Y. et al. (2004). Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279, 32941-32949.
67. Perk, J., Iavarone, A., and Benezra, R. (2005). Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603-614.
68. Pesce, S., and Benezra, R. (1993). The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Mol. Cell Biol. 13, 7874-7880.
69. Ruzinova, M. B., and Benezra, R. (2003). Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410-418.
70. Samanta, J., and Kessler, J. A. (2004). Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131, 4131-4142.
71. Sun, X. H. (1994). Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893-900.
72. Sun, X. H., Copeland, N. G., Jenkins, N. A., and Baltimore, D. (1991). Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell Biol. 11, 5603-5611.
73. Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J. S., Wang, W. F., Forrester, W. C., and Hinds, P. W. (2001). The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8, 303-316.
74. Tu, X., Baffa, R., Luke, S., Prisco, M., and Baserga, R. (2003). Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells. Exp. Cell Res. 288, 119-130.
75. Wang, S., Sdrulla, A., Johnson, J. E., Yokota, Y., and Barres, B. A. (2001). A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 29, 603-614.
76. Wong, Y. C., Wang, X., and Ling, M. T. (2004). Id-1 expression and cell survival. Apoptosis 9, 279-289.
77. Xie, W. F., Zhang, X., and Sandell, L. J. (2000). The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol. 19, 501-509.
78. Yan, W., Young, A. Z., Soares, V. C., Kelley, R., Benezra, R., and Zhuang, Y. (1997). High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell Biol. 17, 7317-7327.
79. Yoshida, C. A., Furuichi, T., Fujita, T., Fukuyama, R., Kanatani, N., Kobayashi, S., Satake, M., Takada, K., and Komori, T. (2002). Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat. Genet. 32, 633-638.
80. Zhao, Z., Zhao, M., Xiao, G., and Franceschi, R. T. (2005). Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol. Ther. 12, 247-253.
81. Zhou, G. et al. (1999). CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8, 2311-2316.